Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, has announced plans to release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the financial markets close. The company will host a conference call and simultaneous webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on the same day to discuss the results.
Investors and interested parties can access the live webcast of the call through Tandem Diabetes Care's Investor Center website. For those wishing to join by phone, a registration link is provided to obtain dial-in details and a personal pin. An archive of the webcast will be available for 30 days following the event on the company's Investor Center website.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), una delle principali aziende nel settore della tecnologia per la somministrazione di insulina e della cura del diabete, ha annunciato piani per rilasciare i suoi risultati finanziari del terzo trimestre 2024 il mercoledì 6 novembre 2024, dopo la chiusura dei mercati finanziari. L'azienda ospiterà una conferenza telefonica e una webcast simultanea alle 4:30 PM ora orientale (1:30 PM ora del Pacifico) lo stesso giorno per discutere i risultati.
Gli investitori e le parti interessate possono accedere alla diretta della webcast tramite il sito web del Centro Investitori di Tandem Diabetes Care. Per coloro che desiderano partecipare telefonicamente, è fornito un link per la registrazione per ottenere i dettagli per la chiamata e un codice personale. Un archivio della webcast sarà disponibile per 30 giorni dopo l'evento sul sito web del Centro Investitori dell'azienda.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), una empresa líder en la entrega de insulina y tecnología para la diabetes, ha anunciado planes para publicar sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024, después del cierre de los mercados financieros. La compañía llevará a cabo una conferencia telefónica y un webcast simultáneo a las 4:30 PM hora del Este (1:30 PM hora del Pacífico) el mismo día para discutir los resultados.
Los inversores y partes interesadas pueden acceder a la transmisión en vivo de la llamada a través del sitio web del Centro de Inversores de Tandem Diabetes Care. Para aquellos que deseen unirse por teléfono, se proporciona un enlace de registro para obtener detalles de marcación y un pin personal. Un archivo del webcast estará disponible durante 30 días después del evento en el sitio web del Centro de Inversores de la compañía.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)는 인슐린 전달 및 당뇨병 기술 분야의 선도적인 회사로서 2024년 3분기 재무 결과를 2024년 11월 6일 수요일에 금융 시장 마감 후 발표할 계획이라고 발표했습니다. 회사는 같은 날 동부 시간 오후 4:30 (태평양 시간 오후 1:30)에 결과를 논의하기 위해 컨퍼런스 콜과 실시간 웹캐스트를 개최합니다.
투자자 및 관심 있는 당사자는 Tandem Diabetes Care의 투자자 센터 웹사이트를 통해 콜의 실시간 웹캐스트에 액세스할 수 있습니다. 전화로 참여하고자 하는 분들을 위해서는 다이얼인 세부 정보와 개인 핀을 얻기 위한 등록 링크가 제공됩니다. 웹캐스트 아카이브는 이벤트 이후 30일 동안 회사의 투자자 센터 웹사이트에서 제공됩니다.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), un leader dans le domaine de la distribution d'insuline et de la technologie du diabète, a annoncé son intention de publier ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024, après la fermeture des marchés financiers. L'entreprise organisera une conférence téléphonique et un webinaire simultané à 16h30, heure de l'Est (13h30, heure du Pacifique) le même jour pour discuter des résultats.
Les investisseurs et les personnes intéressées peuvent accéder au webinaire en direct via le site web du Centre des Investisseurs de Tandem Diabetes Care. Pour ceux qui souhaitent participer par téléphone, un lien d'inscription est fourni pour obtenir les détails de connexion et un code PIN personnel. Un enregistrement du webinaire sera disponible pendant 30 jours après l'événement sur le site web du Centre des Investisseurs de l'entreprise.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ein führendes Unternehmen im Bereich der Insulinabgabe und Diabetes-Technologie, hat Pläne angekündigt, seine Finanzergebnisse für das dritte Quartal 2024 am Mittwoch, den 6. November 2024, nach Börsenschluss zu veröffentlichen. Das Unternehmen wird am gleichen Tag um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) eine Telefonkonferenz und einen simultanen Webcast abhalten, um die Ergebnisse zu diskutieren.
Investoren und interessierte Parteien können den Live-Webcast der Konferenz über die Investor Center-Website von Tandem Diabetes Care abrufen. Für diejenigen, die telefonisch teilnehmen möchten, wird ein Registrierungslink bereitgestellt, um die Einwahldaten und eine persönliche PIN zu erhalten. Ein Archiv des Webcasts wird 30 Tage nach der Veranstaltung auf der Investor Center-Website des Unternehmens verfügbar sein.
- None.
- None.
A live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register.vevent.com/register/BI21747dfdc3fd4a4e98aeeeef73bf87b6) and you will be provided with dial-in details, including a personal pin.
An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241002126716/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
FAQ
When will Tandem Diabetes Care (TNDM) release its Q3 2024 financial results?
What time is Tandem Diabetes Care's (TNDM) Q3 2024 earnings call scheduled for?
How can investors access Tandem Diabetes Care's (TNDM) Q3 2024 earnings call?
Where can I find the archive of Tandem Diabetes Care's (TNDM) Q3 2024 earnings call?
